ECP
Empyrean Capital Partners’s Pfizer PFE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q3 | – | Sell |
-1,875,000
| Closed | -$68M | – | 80 |
|
2018
Q2 | $68M | Sell |
1,875,000
-925,000
| -33% | -$33.6M | 2.16% | 8 |
|
2018
Q1 | $99.4M | Buy |
+2,800,000
| New | +$99.4M | 5.32% | 3 |
|
2016
Q2 | – | Sell |
-2,518,310
| Closed | -$74.6M | – | 90 |
|
2016
Q1 | $74.6M | Buy |
2,518,310
+582,810
| +30% | +$17.3M | 3.12% | 5 |
|
2015
Q4 | $62.5M | Sell |
1,935,500
-288,500
| -13% | -$9.31M | 2.31% | 5 |
|
2015
Q3 | $69.9M | Buy |
2,224,000
+624,000
| +39% | +$19.6M | 3.44% | 3 |
|
2015
Q2 | $53.6M | Buy |
+1,600,000
| New | +$53.6M | 2.5% | 14 |
|
2013
Q3 | – | Sell |
-1,399,115
| Closed | -$39.2M | – | 58 |
|
2013
Q2 | $39.2M | Buy |
+1,399,115
| New | +$39.2M | 0.91% | 18 |
|